Chengheng Liao
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 9
-
- Ubiquitin and proteasome pathways 5
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
- Genomics and Phylogenetic Studies 2
- Studies on Chitinases and Chitosanases 2
- Metabolism, Diabetes, and Cancer 2
- Biotechnology top 10%
-
- Microbial Natural Products and Biosynthesis 3
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Advanced Materials (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Chengheng Liao
22 papers receiving 872 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 277
- Molecular Biology 550
- Immunology 154
- Biotechnology 51
- Oncology 143
Countries citing papers authored by Chengheng Liao
This map shows the geographic impact of Chengheng Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengheng Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengheng Liao more than expected).
Fields of papers citing papers by Chengheng Liao
This network shows the impact of papers produced by Chengheng Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengheng Liao. The network helps show where Chengheng Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengheng Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 23 | |
| 4 | 2023 | 29 | |
| 5 | Tumor hypoxia: From basic knowledge to therapeutic implicationsbreakdown → | 2023 | 110 |
| 6 | 2023 | 0 | |
| 7 | 2022 | 33 | |
| 8 | 2022 | 28 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 49 | |
| 11 | 2020 | 39 | |
| 12 | 2020 | 48 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 72 | |
| 16 | 2019 | 2 | |
| 17 | 2016 | 19 | |
| 18 | 2015 | 17 | |
| 19 | 2015 | 65 | |
| 20 | 2014 | 21 |
About Chengheng Liao
Chengheng Liao is a scholar working on Cancer Research, Biochemistry and Transplantation, having authored 24 papers that have together received 874 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers), Microbial Natural Products and Biosynthesis (3 papers), RNA modifications and cancer (3 papers), Genomics and Phylogenetic Studies (2 papers), Studies on Chitinases and Chitosanases (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (277 citations), Molecular Biology (550 citations) and Immunology (154 citations). Chengheng Liao has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Qing Zhang, Xijuan Liu, Bang‐Ce Ye, Lili Yao, Cheng Zhang, Lianxin Hu, Ya Xu, Ying Zhou, Sébastien Rigali and Rihe Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.